Colon cancer DNA may guide tailored post-surgery care

Circulating tumor DNA (ctDNA)—genetic material shed from tumors into the bloodstream—may help risk-stratify patients with Stage 3 colon cancer by tailoring chemotherapy options after surgery based on risk of cancer recurrence, according to new research co-led by investigators at the Johns Hopkins Kimmel Cancer Center.

Portland Protesters ATTACK Federal Agents — Protesters NOT Arrested!
- Boredom Is A Superpower - Robert Scucci
- Best Side Hustles and Service Businesses with Financial Analysis & Investment Strategy Skills - Zoul
- Woman wins $100K Powerball prize after asking ChatGPT what numbers to play
- Serotonin produced by gut bacteria provides hope for a novel IBS treatment
- Piers Morgan Explodes at Prince Harry, Calls Him ‘Drug-Addled Little Twerp’ After Explosive BBC Interview - Isaiah Amos
- China claims the NSA conducted cyberattacks on its national time center - Jackson Chen

This 5-Minute Fix Could Save You Thousands on Medicare
- RFK Jr.’s MAHA wants to make chemtrail conspiracy theories great again - Beth Mole
- Decoding the Enigma of the Snowball Earth - Arya Chandran
- Key to a long life? World's oldest woman may have answer for her 117 years
- Tom Cruise’s Best Sci-Fi Thriller Is Waiting For You On Netflix - Robert Scucci
- 12 Ways To Relieve Period Cramps Fast - Heidi Cope
- WATCH: Reform UK Mayor STORMS OUT of Interview After BRUTAL GRILLING – Political KNIVES Are OUT in Shock Showdown - Isaiah Amos